Other

Toray Industries, Inc.

Adeza Biomedical Corporation

Toshihiko Terao

Naohiro Kanayama

Tatsuya Kaneko

Masanobu Naruto

David C Casal

The inventors provide an agent for potentiating the effect of interleukin-8, which comprises dehydroepiandrosterone sulfate or a pharmaceutically acceptable salt thereof as an active ingredient. An agent for potentiating the effect of IL-8 of the present invention potentiates the effect of IL-8 by activating the receptor of IL-8 and increasing the number of receptors.

Agent for potentiating the effect of interleukin-8

Method promoting conception by administering IL-8 or MCAF

The present invention provides a method of diagnosing and treating a pregnant female at risk for impending preterm delivery. The method comprises the step of diagnosing imminent preterm delivery by testing with a method that has a sensitivity of at least 80% and a specificity of at least 80%, or by testing for fetal fibronectin in the female's vaginal or cervical secretions. If imminent preterm delivery is indicated by the test, the next step comprises administering to the female a combination of a tocolytic agent, at least one urinastatin-like compound, and at least one antibiotic. Also provided is a pharmaceutical composition of MGMTSRYFYNGTSMA (SEQ ID NO:1), RAFIQLWAFDAVKGK (SEQ ID NO:2) and an antibiotic.

Use of urinastatin-like compounds to prevent premature delivery

Growing community of inventors

Shizuoka, Japan

Toshihiko Terao